Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of "Montreal Cognitive Assessment (MoCA) and Addenbrooke's Cognitive Examination III (ACE-III) "as a Cognitive Screening Tools for the Hearing Impaired

NCT03648502 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT03648502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03648502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of "Montreal Cognitive Assessment (MoCA) and Addenbrooke's Cognitive Examination III (ACE-III) "as a Cognitive Screening Tools for the Hearing Impaired
Lead sponsor
University College, London
Phase
Not applicable
Overall status
Terminated
Start date
November 9, 2018
Completion date
March 13, 2020
Enrollment
78 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

auditory processing disorder, dementia, hearing loss